Elsa Logarinho leads the Aging & Aneuploidy Group, dedicated to high-profile research on the mechanisms of cell cycle deregulation and genomic instability contributing to aging and age-related diseases at IBMC/i3S. One of the major goals of aging research is to develop strategies to delay and even reverse aging. Emerging findings indicate that genomic variations are a relevant and under-recognized mechanism underlying human aging and age-related diseases. In this seminar, Elsa will present recent findings from her group on genetic and pharmacological interventions protecting against genomic instability and addressing their impact on senescence accrual.

The seminar will be exclusively online and open to the scientific community.

Registration is free but mandatory. Find more information about the seminar and registration here.

“The Widespread – Twinning project PhasAGE: Excellence Hub on Phase Transitions in Aging and Age-Related Disorders aims at strengthening the excellence, knowledge and innovation potential of i3S in the emerging field of biomolecular phase transitions. The consortium, headed by IBMC/i3S, includes recognized experts on biological phase separation from Belgium (Peter Tompa and Ludo van Den Bosch, VIB), Spain (Salvador Ventura, Universitat Autònoma de Barcelona) and Italy (Silvio Tosatto, Università di Padova).”